EV/EBITDA
N/A
Mon, 01 Jan 0001 00:00:00 GMT
Summary
- SEEL EV/EBITDA is not available.
Performance
SEEL EV/EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
EV/EBITDA Formula
EV/EBITDA = Enterprise Value
TTM EBITDA
Enterprise Value
TTM EBITDA
TTM EBITDA
SEEL EV/EBITDA Trends
| PeriodPeriod | EV/EBITDAEV/EBITDA | Enterprise valueEnterprise value | PricePrice |
|---|---|---|---|
| 6 m6 months | - | - | - |
| 1 y1 year | - | - | - |
| 5 y5 years | - | - | - |
SEEL EV/EBITDA Highs & Lows
| PeriodPeriod | HighHigh | Current vs highvs high | LowLow | Current vs lowvs low | |
|---|---|---|---|---|---|
| 1 m | 1-month | ||||
| 3 m | 3-month | 2.37 | 2.32 | ||
| 6 m | 6-month | 2.87 | 2.32 | ||
| 1 y | 1-year | 2.95 | -0.80 | ||
| 3 y | 3-year | 2.95 | -2.63 | ||
| 5 y | 5-year | 2.95 | -20.20 | ||
| alltime | all time | 6.99 | -20.20 |
Seelos Therapeutics EV/EBITDA History
| Date | Value |
|---|---|
| 2024 | 2.34(-454.5%) |
| 2023 | -0.66(-37.1%) |
| 2022 | -1.05(-39.7%) |
| 2021 | -1.74(-59.0%) |
| 2020 | -4.24(+748.0%) |
| 2019 | -0.50(+733.3%) |
| 2018 | -0.06(-95.3%) |
| 2017 | -1.29(-57.3%) |
| 2016 | -3.02(+874.2%) |
| 2015 | -0.31(-203.3%) |
| 2014 | 0.30(-76.0%) |
| 2013 | 1.25(+160.4%) |
| Date | Value |
|---|---|
| 2012 | 0.48(+140.0%) |
| 2011 | 0.20(-13.0%) |
| 2010 | 0.23(-105.3%) |
| 2009 | -4.35(+987.5%) |
| 2008 | -0.40(-2100.0%) |
| 2007 | 0.02(-97.4%) |
| 2006 | 0.78(-439.1%) |
| 2005 | -0.23(-560.0%) |
| 2004 | 0.05(-87.5%) |
| 2003 | 0.40(-310.5%) |
| 2002 | -0.19(-126.8%) |
| 2001 | 0.71(-74.7%) |
| 2000 | 2.81 |
FAQ
- What is the all time high EV/EBITDA for Seelos Therapeutics?
What is the all time high EV/EBITDA for Seelos Therapeutics?
Seelos Therapeutics all-time high EV/EBITDA is 6.99